Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special
Juan Andres, insider at Moderna
Juan Andres Insider Alerts

Get notified the next time Juan Andres buys or sells Moderna stock. Enter your email address below to get our daily insider buying and selling report.

Juan Andres Insider Information

Insider of Moderna
As Chief Technical Operations and Quality Officer, Juan Andres is responsible for the supply of product required for Moderna’s preclinical and clinical development programs, as well as scaling the CMC (chemistry, manufacturing and controls) processes across Moderna’s portfolio. Mr. Andres also will lead all CMC late-stage development and future commercialization activities.

Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions. In this role, he had responsibility for all of Novartis’ manufacturing sites, and related support functions and technologies worldwide, overseeing small molecules drug substance and drug product, as well as biologics drug substance, drug product and technical development. Mr. Andres’ previous roles at Novartis included Group Novartis Quality Head, Global Head of Technical Research and Development, and Global Pharmaceutical Operations Head. Prior to Novartis, Mr. Andres worked at Eli Lilly & Co. for 18 years in a variety of manufacturing, production and quality roles in the United States, Puerto Rico, UK and Spain, most recently serving as Vice President, Pharmaceutical Manufacturing.

Mr. Andres holds a Master degree in Pharmacy from Alcala de Henares University in Madrid and completed an advanced development program at the London Business School.

What is Juan Andres' net worth?

The estimated net worth of Juan Andres is at least $1.65 million as of September 10th, 2021. Mr. Andres owns 5,000 shares of Moderna stock worth more than $1,648,150 as of November 27th. This net worth evaluation does not reflect any other assets that Mr. Andres may own. Learn More.

What is Juan Andres' salary?

As the Insider of Moderna, Inc., Mr. Andres earned a total compensation package of $4,247,823.00 in 2020. Mr. Andres earned a salary of $548,712.00, a bonus of $662,400.00, stock awards of $750,000.00, options awards of $2,250,000.00, and other compensation of $36,711.00.

How do I contact Juan Andres?

The corporate mailing address for Mr. Andres and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected]

Has Juan Andres been buying or selling shares of Moderna?

Within the last three months, Juan Andres has sold $34,737,950.00 in Moderna stock. Most recently, Juan Andres sold 5,000 shares of the business's stock in a transaction on Wednesday, November 24th. The shares were sold at an average price of $273.01, for a transaction totalling $1,365,050.00.

Who are Moderna's active insiders?

Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (CEO), W. Cornwell (Director), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), and Tal Zaks (Insider).

Are insiders buying or selling shares of Moderna?

During the last year, Moderna insiders bought shares 3 times. They purchased a total of 423,616 shares worth more than $15,619,184.48. During the last year, insiders at the sold shares 203 times. They sold a total of 6,998,621 shares worth more than $1,154,663,018.30. The most recent insider tranaction occured on November, 24th when CEO Stephane Bancel sold 9,000 shares worth more than $2,457,090.00. Insiders at Moderna own 19.4 % of the company.

Information on this page was last updated on 11/24/2021.

Juan Andres Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/24/2021Sell5,000$273.01$1,365,050.00View SEC Filing Icon  
11/22/2021Sell15,000$268.18$4,022,700.00View SEC Filing Icon  
11/19/2021Sell5,000$265.71$1,328,550.00View SEC Filing Icon  
11/17/2021Sell5,000$234.57$1,172,850.00View SEC Filing Icon  
11/15/2021Sell5,000$231.01$1,155,050.00View SEC Filing Icon  
11/10/2021Sell5,000$230.00$1,150,000.00View SEC Filing Icon  
11/8/2021Sell15,000$233.13$3,496,950.00View SEC Filing Icon  
11/5/2021Sell5,000$240.00$1,200,000.00View SEC Filing Icon  
11/1/2021Sell5,000$335.00$1,675,000.00View SEC Filing Icon  
10/29/2021Sell5,000$344.49$1,722,450.00View SEC Filing Icon  
10/27/2021Sell5,000$344.25$1,721,250.00View SEC Filing Icon  
10/25/2021Sell15,000$327.36$4,910,400.00View SEC Filing Icon  
10/22/2021Sell5,000$333.00$1,665,000.00View SEC Filing Icon  
10/20/2021Sell5,000$333.90$1,669,500.00View SEC Filing Icon  
10/18/2021Sell5,000$322.26$1,611,300.00View SEC Filing Icon  
10/15/2021Sell5,000$341.25$1,706,250.00View SEC Filing Icon  
10/13/2021Sell5,000$314.90$1,574,500.00View SEC Filing Icon  
10/6/2021Sell5,000$318.23$1,591,150.00View SEC Filing Icon  
9/29/2021Sell5,000$393.44$1,967,200.00View SEC Filing Icon  
9/27/2021Sell15,000$429.38$6,440,700.00View SEC Filing Icon  
9/27/2021Sell15,000$429.38$6,440,700.00View SEC Filing Icon  
9/22/2021Sell5,000$433.00$2,165,000.00View SEC Filing Icon  
9/20/2021Sell5,000$417.62$2,088,100.00View SEC Filing Icon  
9/17/2021Sell5,000$438.24$2,191,200.00View SEC Filing Icon  
9/15/2021Sell5,000$427.13$2,135,650.00View SEC Filing Icon  
9/13/2021Sell15,000$447.41$6,711,150.00View SEC Filing Icon  
9/10/2021Sell5,000$461.85$2,309,250.005,000View SEC Filing Icon  
9/1/2021Sell5,000$381.82$1,909,100.00View SEC Filing Icon  
8/30/2021Sell15,000$368.93$5,533,950.00View SEC Filing Icon  
8/27/2021Sell5,000$398.12$1,990,600.005,000View SEC Filing Icon  
8/25/2021Sell5,000$391.59$1,957,950.00View SEC Filing Icon  
8/18/2021Sell5,000$407.00$2,035,000.005,000View SEC Filing Icon  
8/13/2021Sell5,000$405.00$2,025,000.005,000View SEC Filing Icon  
8/4/2021Sell5,000$384.85$1,924,250.005,000View SEC Filing Icon  
7/28/2021Sell5,000$332.92$1,664,600.00View SEC Filing Icon  
7/23/2021Sell5,000$330.90$1,654,500.005,000View SEC Filing Icon  
7/21/2021Sell5,000$299.00$1,495,000.005,000View SEC Filing Icon  
7/19/2021Sell15,000$284.40$4,266,000.00View SEC Filing Icon  
7/16/2021Sell5,000$276.51$1,382,550.00View SEC Filing Icon  
7/14/2021Sell5,000$237.22$1,186,100.00View SEC Filing Icon  
7/12/2021Sell5,000$230.71$1,153,550.00View SEC Filing Icon  
7/6/2021Sell5,000$229.62$1,148,100.00View SEC Filing Icon  
6/23/2021Sell5,000$219.65$1,098,250.005,000View SEC Filing Icon  
6/21/2021Sell5,000$200.86$1,004,300.005,000View SEC Filing Icon  
6/14/2021Sell5,000$213.32$1,066,600.005,000View SEC Filing Icon  
6/7/2021Sell5,000$207.04$1,035,200.005,000View SEC Filing Icon  
5/5/2021Sell5,000$178.34$891,700.005,000View SEC Filing Icon  
4/28/2021Sell5,000$182.32$911,600.005,000View SEC Filing Icon  
4/26/2021Sell5,000$171.77$858,850.005,000View SEC Filing Icon  
4/21/2021Sell5,000$158.60$793,000.005,000View SEC Filing Icon  
4/19/2021Sell5,000$166.17$830,850.005,000View SEC Filing Icon  
4/14/2021Sell5,000$153.75$768,750.005,000View SEC Filing Icon  
4/7/2021Sell5,000$131.63$658,150.005,000View SEC Filing Icon  
3/29/2021Sell5,000$130.05$650,250.005,000View SEC Filing Icon  
3/17/2021Sell5,000$149.78$748,900.005,000View SEC Filing Icon  
3/10/2021Sell5,000$133.24$666,200.005,000View SEC Filing Icon  
2/1/2021Sell5,000$172.99$864,950.005,000View SEC Filing Icon  
1/11/2021Sell5,000$112.83$564,150.005,000View SEC Filing Icon  
5/13/2020Sell127,500$64.67$8,245,425.00127,500View SEC Filing Icon  
5/1/2020Sell25,000$48.05$1,201,250.0025,000View SEC Filing Icon  
4/15/2020Sell23,403$37.11$868,485.3323,403View SEC Filing Icon  
4/6/2020Sell300$35.13$10,539.00300View SEC Filing Icon  
See Full Table

Juan Andres Buying and Selling Activity at Moderna

This chart shows Juan Andres's buying and selling at Moderna by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Moderna Company Overview

Moderna logo
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $329.63
Low: $313.00
High: $350.15

50 Day Range

MA: $320.57
Low: $225.82
High: $454.60

2 Week Range

Now: $329.63
Low: $102.66
High: $497.49


35,901,209 shs

Average Volume

13,342,658 shs

Market Capitalization

$133.65 billion

P/E Ratio


Dividend Yield



Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special